Zobrazeno 1 - 9
of 9
pro vyhledávání: '"Francisco J. Cabral-Amador"'
Autor:
Camila Manrique-Acevedo, Jaume Padilla, Huma Naz, Makenzie L. Woodford, Thaysa Ghiarone, Annayya R. Aroor, Jack L. Hulse, Francisco J. Cabral-Amador, Vanesa Martinez-Diaz, Chetan P. Hans, Adam Whaley-Connell, Luis A. Martinez-Lemus, Guido Lastra
Publikováno v:
Frontiers in Physiology, Vol 12 (2021)
Enhanced mineralocorticoid receptor (MR) signaling is critical to the development of endothelial dysfunction and arterial stiffening. However, there is a lack of knowledge about the role of MR-induced adipose tissue inflammation in the genesis of vas
Externí odkaz:
https://doaj.org/article/68eda70340d34485a839842d3f9aa89c
Autor:
Chelsea Chang, Alcibiades Fleires, Alfarooq Alshaikhli, Hector Arredondo, Diana Gavilanes, Francisco J Cabral-Amador, Jonathon Cantu, Daniela Bazan, Kathryn Oliveira Oliveira, Rene Verduzco, Lina Pedraza
Publikováno v:
BMJ Open Quality, Vol 13, Iss 1 (2024)
Inpatient hyperglycaemia is associated with an increase in morbidity and mortality, number of rehospitalisations and length of hospitalisation. Although the advantages of proper glycaemic control in hospitalised patients with diabetes are well establ
Externí odkaz:
https://doaj.org/article/da03d89ccb384e37b7c162fbf3d4d13c
Autor:
Thomas J. Jurrissen, Francisco I. Ramirez-Perez, Francisco J. Cabral-Amador, Rogerio N. Soares, Ryan J. Pettit-Mee, Edgar E. Betancourt-Cortes, Neil J. McMillan, Neekun Sharma, Helena N. M. Rocha, Shumpei Fujie, Mariana Morales-Quinones, Yoskaly Lazo-Fernandez, Andrew A. Butler, Subhashis Banerjee, Harold S. Sacks, Jamal A. Ibdah, Elizabeth J. Parks, R. Scott Rector, Camila Manrique-Acevedo, Luis A. Martinez-Lemus, Jaume Padilla
Publikováno v:
American Journal of Physiology-Heart and Circulatory Physiology. 323:H879-H891
Adropin is a peptide largely secreted by the liver and known to regulate energy homeostasis; however, it also exerts cardiovascular effects. Herein, we tested the hypothesis that low circulating levels of adropin in obesity and type 2 diabetes (T2D)
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::7064f696e54b677f7e59ffa567c26a2c
https://doi.org/10.1152/ajpheart.00385.2022
https://doi.org/10.1152/ajpheart.00385.2022
Autor:
Thaysa Ghiarone, Jorge A. Castorena-Gonzalez, Christopher A. Foote, Francisco I. Ramirez-Perez, Larissa Ferreira-Santos, Francisco J. Cabral-Amador, Roger de la Torre, Rama R. Ganga, Andrew A. Wheeler, Camila Manrique-Acevedo, Jaume Padilla, Luis A. Martinez-Lemus
Publikováno v:
American Journal of Physiology-Heart and Circulatory Physiology. 323:H688-H701
Inflammation and vascular insulin resistance are hallmarks of type 2 diabetes (T2D). However, several potential mechanisms causing abnormal endothelial insulin signaling in T2D need further investigation. Evidence indicates that the activity of ADAM1
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::8cd0061d1736e286b65919b98eccc70f
https://doi.org/10.1152/ajpheart.00039.2022
https://doi.org/10.1152/ajpheart.00039.2022
Autor:
Ryan J. Pettit-Mee, Gavin Power, Francisco J. Cabral-Amador, Francisco I. Ramirez-Perez, Rogerio N. Soares, Neekun Sharma, Ying Liu, Demetra D. Christou, Jill A. Kanaley, Luis A. Martinez-Lemus, Camila Manrique-Acevedo, Jaume Padilla
Publikováno v:
Am J Physiol Regul Integr Comp Physiol
Impaired endothelial insulin signaling and consequent blunting of insulin-induced vasodilation is a feature of type 2 diabetes (T2D) that contributes to vascular disease and glycemic dysregulation. However, the molecular mechanisms underlying endothe
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::69a1579077331c2207c0033666d5a3ad
https://doi.org/10.1152/ajpregu.00006.2022
https://doi.org/10.1152/ajpregu.00006.2022
Autor:
Francisco I. Ramirez-Perez, Francisco J. Cabral-Amador, Adam T. Whaley-Connell, Annayya R. Aroor, Mariana Morales-Quinones, Makenzie L. Woodford, Thaysa Ghiarone, Larissa Ferreira-Santos, Thomas J. Jurrissen, Camila M. Manrique-Acevedo, GuangHong Jia, Vincent G. DeMarco, Jaume Padilla, Luis A. Martinez-Lemus, Guido Lastra
Publikováno v:
Am J Physiol Heart Circ Physiol
Consumption of diets high in fat, sugar, and salt (Western diet, WD) is associated with accelerated arterial stiffening, a major independent risk factor for cardiovascular disease (CVD). Women with obesity are more prone to develop arterial stiffenin
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::67c64eaac436c838ffbf56fc7cf734e0
https://doi.org/10.1152/ajpheart.00431.2021
https://doi.org/10.1152/ajpheart.00431.2021
Autor:
Rogerio N. Soares, Francisco I. Ramirez-Perez, Francisco J. Cabral-Amador, Mariana Morales-Quinones, Christopher A. Foote, Thaysa Ghiarone, Neekun Sharma, Gavin Power, James A. Smith, R. Scott Rector, Luis A. Martinez-Lemus, Jaume Padilla, Camila Manrique-Acevedo
Publikováno v:
GeroScience. 44(3)
Aging of the vasculature is characterized by endothelial dysfunction and arterial stiffening, two key events in the pathogenesis of cardiovascular disease (CVD). Treatment with sodium glucose transporter 2 (SGLT2) inhibitors is now known to decrease
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::22dbb7b335e0ad4924a38150f134a9e6
https://pubmed.ncbi.nlm.nih.gov/35426600
https://pubmed.ncbi.nlm.nih.gov/35426600
Autor:
Francisco J Cabral-Amador, Christopher A. Foote, Camila Margarita Manrique Acevedo, Thaysa Ghiarone, Francisco I. Ramirez-Perez, Luis A. Martinez-Lemus, Hans Vink, Mariana Morales-Quinones, Thomas J. Jurrissen, Rogério Nogueira Soares, Jaume Padilla
Publikováno v:
Hypertension. 78
Arterial stiffening, a characteristic feature of type 2 diabetes, is an important contributor to the development and progression of cardiovascular disease (CVD). Thus, a better understanding of the precipitating factors underlying arterial stiffening
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::99e484cd25689be62c721d439ae97734
https://doi.org/10.1161/hyp.78.suppl_1.p279
https://doi.org/10.1161/hyp.78.suppl_1.p279
Autor:
Francisco J Cabral-Amador, Makenzie L Woodford, Francisco I. Ramirez-Perez, Tadashi Yoshida, Mariana Morales-Quinones, Luis A. Martinez-Lemus, David A. Brenner, Camila Manrique-Acevedo, Jaume Padilla, Bysani Chandrasekar, Zachary I. Grunewald
Publikováno v:
Am J Physiol Heart Circ Physiol
Arterial stiffening, a characteristic feature of obesity and type 2 diabetes, contributes to the development and progression of cardiovascular diseases (CVD). Currently, no effective prophylaxis or therapeutics is available to prevent or treat arteri
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::996033ef98186f681b6ffc38adc357c1
https://pubmed.ncbi.nlm.nih.gov/34242094
https://pubmed.ncbi.nlm.nih.gov/34242094